Evaluating Galbanic Acid and Arsenic Trioxide Effects on ATL Cells

Maryam Mahdifar from Mashhad University of Medical Sciences investigated the synergistic anti-cancer effects of galbanic acid and arsenic trioxide on MT-2 cells, an Adult T-cell leukemia cell line. The study measured IC50 values, cell viability, cell cycle distribution, P-glycoprotein activity, and mRNA expression levels for six key genes. Results indicate the combination synergistically inhibited cell proliferation and induced apoptosis.

Use Cases

• Modeling drug synergy effects based on IC50 values and cell viability assays.
• Analyzing gene expression changes based on mRNA levels of RelA, p53, CDK4, c-MYC, and c-FLIP isoforms.
• Studying P-glycoprotein efflux pump inhibition based on mitoxantrone accumulation rates.
• Investigating relationships between apoptotic markers based on statistical links between p53 and c-FLIPS expression.

Strengths

• Study design includes specific experimental concentrations (20 µM GBA, 4 µM ATO).
• Analysis covers multiple biological endpoints: cell viability, cycle distribution, efflux activity, and gene expression.
• Statistical analysis revealed a significant relation between p53 and c-FLIPS expression.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Last update date is unknown; freshness unverified.

Provenance

Source

Maryam Mahdifar, Mashhad University of Medical Sciences

Collection Method

Experimental laboratory study on the MT-2 cell line.